Chemotherapy Could Prime Tumors for PD-1 Blockade
Induction strategies in triple negative breast cancer enhanced sensitivity to PD-1 blockade.
Breast Cancer
In-House or Centralized Testing? Debating Whether Genomic Sequencing Is Best Conducted at Home
Genomic analysis of tumors and tests measuring certain biomarkers can be done in-house or sent out. What are the costs and benefits of each approach?
Bioimpedance Spectroscopy May Identify Lymphedema Earlier
Use of an electrical current to measure extracellular fluid volume — bioimpedance spectroscopy (BIS) — may identify postoperative breast cancer patients at risk for lymphedema at an earlier stage, when intervention may more effectively prevent progression.
ctDNA Makes Progress as an Early Treatment Indicator in Breast Cancer
Despite its limitations, ctDNA is emerging as a potentially powerful diagnostic tool.
Mammo-Based Deep Learning Model Assesses Breast Cancer Risk
Mammography-based deep learning (DL) breast cancer risk models are more accurate than models that consider traditional risk factors and breast density.
What Do Surrogate End Points Actually Predict?
As understanding of cancer improves, drug development could become accelerated, necessitating a means for determining whether a drug is actually effective.
Test Predicts Benefit of Chemo in ER+, HER2− Breast Cancer
EndoPredict (EPclin) is prognostic for distant recurrence (DR) in women with estrogen receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
New Lesions ID’d on Breast MRI During Treatment Likely Benign
magnetic resonance imaging (MRI) examinations with new suspicious findings are unlikely to represent a new site of malignancy
Enhanced Reimbursement Incentives for Generic Cancer Drugs Found Not to Affect Prescribing Patterns
Critics of the study say they are not surprised by the study’s conclusions, as oncologists make treatment decisions based on best treatment course, not money.
Clinicians Believe Link Between Breast Pain, Cancer Is Weak
Although most believe that the correlation between breast pain and breast cancer is weak, many referring clinicians will order imaging.
Next post in Breast Cancer
